STAA
Price
$26.50
Change
-$0.22 (-0.82%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
1.31B
21 days until earnings call
WST
Price
$268.04
Change
+$2.07 (+0.78%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
19.27B
15 days until earnings call
Interact to see
Advertisement

STAA vs WST

Header iconSTAA vs WST Comparison
Open Charts STAA vs WSTBanner chart's image
STAAR Surgical
Price$26.50
Change-$0.22 (-0.82%)
Volume$14.04K
Capitalization1.31B
West Pharmaceutical Services
Price$268.04
Change+$2.07 (+0.78%)
Volume$3.05K
Capitalization19.27B
STAA vs WST Comparison Chart in %
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STAA vs. WST commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STAA is a Buy and WST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (STAA: $26.50 vs. WST: $267.93)
Brand notoriety: STAA and WST are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: STAA: 69% vs. WST: 106%
Market capitalization -- STAA: $1.31B vs. WST: $19.27B
STAA [@Pharmaceuticals: Other] is valued at $1.31B. WST’s [@Pharmaceuticals: Other] market capitalization is $19.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.63B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.28B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STAA’s FA Score shows that 0 FA rating(s) are green whileWST’s FA Score has 0 green FA rating(s).

  • STAA’s FA Score: 0 green, 5 red.
  • WST’s FA Score: 0 green, 5 red.
According to our system of comparison, WST is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STAA’s TA Score shows that 3 TA indicator(s) are bullish while WST’s TA Score has 5 bullish TA indicator(s).

  • STAA’s TA Score: 3 bullish, 4 bearish.
  • WST’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, WST is a better buy in the short-term than STAA.

Price Growth

STAA (@Pharmaceuticals: Other) experienced а -2.50% price change this week, while WST (@Pharmaceuticals: Other) price change was -1.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.64%. For the same industry, the average monthly price growth was +2.49%, and the average quarterly price growth was +18.65%.

Reported Earning Dates

STAA is expected to report earnings on Oct 29, 2025.

WST is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.64% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WST($19.3B) has a higher market cap than STAA($1.31B). STAA has higher P/E ratio than WST: STAA (49.73) vs WST (40.11). STAA YTD gains are higher at: 10.004 vs. WST (-18.603). WST has higher annual earnings (EBITDA): 760M vs. STAA (-73.24M). WST has more cash in the bank: 510M vs. STAA (190M). STAA has less debt than WST: STAA (40.5M) vs WST (303M). WST has higher revenues than STAA: WST (2.96B) vs STAA (224M).
STAAWSTSTAA / WST
Capitalization1.31B19.3B7%
EBITDA-73.24M760M-10%
Gain YTD10.004-18.603-54%
P/E Ratio49.7340.11124%
Revenue224M2.96B8%
Total Cash190M510M37%
Total Debt40.5M303M13%
FUNDAMENTALS RATINGS
STAA vs WST: Fundamental Ratings
STAA
WST
OUTLOOK RATING
1..100
48
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9650
PRICE GROWTH RATING
1..100
4246
P/E GROWTH RATING
1..100
8856
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STAA's Valuation (85) in the Medical Specialties industry is in the same range as WST (86). This means that STAA’s stock grew similarly to WST’s over the last 12 months.

STAA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as WST (100). This means that STAA’s stock grew similarly to WST’s over the last 12 months.

WST's SMR Rating (50) in the Medical Specialties industry is somewhat better than the same rating for STAA (96). This means that WST’s stock grew somewhat faster than STAA’s over the last 12 months.

STAA's Price Growth Rating (42) in the Medical Specialties industry is in the same range as WST (46). This means that STAA’s stock grew similarly to WST’s over the last 12 months.

WST's P/E Growth Rating (56) in the Medical Specialties industry is in the same range as STAA (88). This means that WST’s stock grew similarly to STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STAAWST
RSI
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 7 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IAE7.620.05
+0.66%
VOYA ASIA PACIFIC HIGH DIVIDEND EQUITY Income FUND
HEAL32.850.03
+0.09%
Global X HealthTech ETF
DJAN42.23-0.07
-0.16%
FT Vest US Equity Dp Bffr ETF Jan
GGRW35.28-0.16
-0.45%
Gabelli Growth Innovators ETF
NULG99.70-0.66
-0.66%
Nuveen ESG Large-Cap Growth ETF